These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6512040)

  • 1. Lymph node histopathology in Sézary syndrome.
    Buzzanga J; Banks PM; Winkelmann RK
    J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):880-8. PubMed ID: 6512040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome).
    Galindo LM; Garcia FU; Hanau CA; Lessin SR; Jhala N; Bigler RD; Vonderheid EC
    Am J Clin Pathol; 2000 Jun; 113(6):865-71. PubMed ID: 10874888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
    Sausville EA; Eddy JL; Makuch RW; Fischmann AB; Schechter GP; Matthews M; Glatstein E; Ihde DC; Kaye F; Veach SR
    Ann Intern Med; 1988 Sep; 109(5):372-82. PubMed ID: 3408055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system.
    Sausville EA; Worsham GF; Matthews MJ; Makuch RW; Fischmann AB; Schechter GP; Gazdar AF; Bunn PA
    Hum Pathol; 1985 Nov; 16(11):1098-109. PubMed ID: 3876976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A histologic study of lymph nodes from patients with the Sézary syndrome.
    Scheffer E; Meijer CJ; van Vloten WA; Willemze R
    Cancer; 1986 Jun; 57(12):2375-80. PubMed ID: 2938724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymph node histopathologic aspects in cutaneous lymphomas of the mycosis fungoides or Sézary syndrome type. Retrospective study of 98 biopsies].
    Wechsler J; Diebold J; Gerard-Marchant R
    Ann Pathol; 1987; 7(2):122-9. PubMed ID: 3620027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
    Sentis HJ; Willemze R; Scheffer E
    J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sézary syndrome. A clinicopathologic study of 39 cases.
    Buechner SA; Winkelmann RK
    Arch Dermatol; 1983 Dec; 119(12):979-86. PubMed ID: 6651315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
    Willemze R; Scheffer E; Meijer CJ
    Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymph node localization of epidermotropic T malignant lymphomas (mycosis fungoides and Sézary's syndrome)].
    Wechsler J; Diebold J; Gérard-Marchant R
    Bull Cancer; 1984; 71(2):89-99. PubMed ID: 6610451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopsy correlation of surface area vs. single-axis measurements on computed tomography scan of lymph nodes in patients with erythrodermic mycosis fungoides and Sézary syndrome.
    Haththotuwa R; Zilinskiene L; Oliff J; Vydianath B; Amel-Kashipaz R; Stevens A; Shah F; Chaganti S; Scarisbrick J
    Br J Dermatol; 2017 Sep; 177(3):877-878. PubMed ID: 28012157
    [No Abstract]   [Full Text] [Related]  

  • 16. Sézary syndrome with a 14:14 (q12:q31) translocation.
    Shah-Reddy I; Mayeda K; Mirchandani I; Koppitch FC
    Cancer; 1982 Jan; 49(1):75-9. PubMed ID: 7053821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
    Kim YH; Bishop K; Varghese A; Hoppe RT
    Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light microscopic, S-100 immunostaining, and ultrastructural analysis of dermatopathic lymphadenopathy, with and without associated mycosis fungoides.
    Herrera GA
    Am J Clin Pathol; 1987 Feb; 87(2):187-95. PubMed ID: 3544800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sézary syndrome in a Malay--case report and literature review.
    Yuen P; Chan HL; Lee YS
    Singapore Med J; 2001 May; 42(5):224-7. PubMed ID: 11513062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatopathic lymphadenopathy. Comparison of cases associated and unassociated with mycosis fungoides.
    Burke JS; Colby TV
    Am J Surg Pathol; 1981 Jun; 5(4):343-52. PubMed ID: 7270782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.